Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

NCT06293261 · clinicaltrials.gov ↗

COMPLETED

Status

5047

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Hypercholesterolemia

Interventions

DRUG: Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg

Sponsor

Yuhan Corporation